XENOBIOTIC AND ENDOBIOTIC INHIBITORS OF CYTOCHROME-P-450DBL FUNCTION, THE TARGET OF THE DEBRISOQUINE SPARTEINE TYPE POLYMORPHISM

被引：114

作者：

FONNEPFISTER, R

MEYER, UA

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 20期

关键词：

D O I：

10.1016/0006-2952(88)90063-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3829 / 3835

页数：7

共 38 条

[1]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[2] GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].

BOOBIS, AR ;

MURRAY, S ;

HAMPDEN, CE ;

DAVIES, DS .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71

[3] SIMPLE GRAPHICAL METHOD FOR DETERMINING INHIBITION CONSTANTS OF MIXED, UNCOMPETITIVE AND NON-COMPETITIVE INHIBITORS [J].

CORNISHB.A .

BIOCHEMICAL JOURNAL, 1974, 137 (01) :143-144

[4] STERIC CONFIGURATION AND POLYMORPHIC OXIDATION OF LIPOPHILIC BETA-ADRENOCEPTOR BLOCKING-AGENTS - INVIVO INVITRO CORRELATIONS [J].

DAYER, P ;

LEEMANN, T ;

GUT, J ;

KRONBACH, T ;

KUPFER, A ;

FRANCIS, R ;

MEYER, UA .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (03) :399-400

[5] THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].

DIXON, M .

BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171

[6] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[7]

EICHELBAUM M, 1984, FED PROC, V43, P2298

[8]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[9] MPTP, THE NEUROTOXIN INDUCING PARKINSONS-DISEASE, IS A POTENT COMPETITIVE INHIBITOR OF HUMAN AND RAT CYTOCHROME-P450 ISOZYMES (P450BUFI, P450DB1) CATALYZING DEBRISOQUINE 4-HYDROXYLATION [J].

FONNEPFISTER, R ;

BARGETZI, MJ ;

MEYER, UA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :1144-1150

[10]

HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0

← 1 2 3 4 →